🇺🇸 Ovcon® 35 Fe in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Ovcon® 35 Fe on 14 November 2003

Marketing authorisation

FDA — authorised 14 November 2003

Application: NDA021490
Marketing authorisation holder: APIL
Local brand name: FEMCON FE
Indication: TABLET — ORAL
Status: approved

Read official source →

Frequently asked questions

Is Ovcon® 35 Fe approved in United States?

Yes. FDA authorised it on 14 November 2003.

Who is the marketing authorisation holder for Ovcon® 35 Fe in United States?

APIL holds the US marketing authorisation.